Cargando…
Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents
Emerging drug resistance is generating an urgent need for novel and effective antibiotics. A promising target that has not yet been addressed by approved antibiotics is the bacterial DNA gyrase subunit B (GyrB), and GyrB inhibitors could be effective against drug-resistant bacteria, such as methicil...
Autores principales: | Xue, Wenjie, Wang, Yaling, Lian, Xu, Li, Xueyao, Pang, Jing, Kirchmair, Johannes, Wu, Kebin, Han, Zunsheng, You, Xuefu, Zhang, Hongmin, Xia, Jie, Wu, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186351/ https://www.ncbi.nlm.nih.gov/pubmed/36278813 http://dx.doi.org/10.1080/14756366.2022.2084088 |
Ejemplares similares
-
DNA Gyrase as a Target for Quinolones
por: Spencer, Angela C., et al.
Publicado: (2023) -
DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana
por: Evans-Roberts, Katherine M., et al.
Publicado: (2016) -
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus
por: Negatu, Dereje Abate, et al.
Publicado: (2021) -
Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase
por: Piton, Jérémie, et al.
Publicado: (2010) -
Interactions between Quinolones and Bacillus
anthracis Gyrase and the Basis of Drug Resistance
por: Ashley, Rachel E., et al.
Publicado: (2017)